Table 2.
Incidence and HRs of gallbladder stone disease (GSD in type 1 diabetes cohort or type 2 diabetes cohort compared with the corresponding control cohort.
Type 1 diabetes | Type 2 diabetes | |||
---|---|---|---|---|
No | Yes | No | Yes | |
(N = 28,060) | (N = 7,015) | (N = 51,689) | (N = 51,689) | |
Person-years | 181,341 | 45,985 | 453,383 | 435,806 |
Follow-up time (y) Median ± (SD) | 6.46 ± 3.95 | 6.56 ± 3.95 | 6.33 ± 3.40 | 6.58 ± 3.92 |
GSD | ||||
Event | 134 | 17 | 1611 | 2249 |
Rate# | 7.39 | 3.70 | 35.5 | 51.6 |
Crude HR (95% CI) | 1 (Reference) | 0.50 (0.30, 0.83)** | 1 (Reference) | 1.45 (1.36, 1.54)*** |
Adjusted HR (95% CI) | 1 (Reference) | 0.48 (0.25, 0.92)* | 1 (Reference) | 1.55 (1.41, 1.69)*** |
Rate#, incidence rate, per 10,000 person-years; Crude HR, relative hazard ratio; SD, standard deviation; 95% CI, 95% confidence interval; CAD, coronary artery disease; Adjusted HR, multivariate analysis including age, sex, hypertension, hyperlipidemia, cirrhosis, stroke, CAD, chronic kidney diseases, alcohol-related illness, obesity, and number of parity.
P < 0.05,
P < 0.01,
P < 0.001.